Bellevue Life Sciences Acquisition Corp.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Bellevue Life Sciences Acquisition Corp.'s balance sheet done over the years? Its assets were worth $36,627,733 last year. 11% of Bellevue Life Sciences Acquisition Corp.’s total assets is currently financed by debt. Its liabilities reached the amount of $4,108,272.
Debt to Assets
| 2023 | 36627733 | 4.10M | 11.22% |
|---|
BLACU Balance Sheet (2023 – 2023)
| 2023 | |
|---|---|
Assets | |
Current assets: | |
Cash and cash equivalents | 15.41K |
Short term investments | 0 |
Net receivables | 0 |
Inventory | 0 |
Other current assets | 7.20K |
Total current assets | 22.62K |
Non-current assets: | |
Property, Plant and Equipment | 0 |
Goodwill | 0 |
Intangible assets | 0 |
Long term investments | 36.60M |
Other non-current assets | 0 |
Total non-current assets | 36.60M |
Total assets | 36.62M |
Liabilities | |
| Current liabilities: | |
Accounts payable | |
Deferred revenue | 0 |
Short term debt | 0 |
Total current liabilities | 2.03M |
| Non-current liabilities: | |
Long term debt | 0 |
Deferred tax | 0 |
Other non-current liabilities | 2.07M |
Total non-current liabilities | 2.07M |
Total liabilities | 4.10M |
| Data source |